Advertisement Feature in 2022

The physicist who spearheaded optical lattice clock research, which has enabled the measurement of spacetime, receives the 43rd Honda Prize.

The global innovation hubs index has doubled the number of cities in its rankings to 100, extending its reach to many more policymakers and entrepreneurs.

The GIHI2022 continues to apply scientific, objective, independent and impartial principles in evaluating 100 GIHs by three indicators known as research innovation, innovation economy, and innovation ecosystem, providing a reference for policy-makers, entrepreneurs, and practitioners.

A conversation with Philippe Neimark, the new general manager of Anthogyr.

Euro-centric genomic data skew attempts to calculate polygenic risk. Statistical adjustments allow research to move on, even if they don’t solve the underlying problem.

The ability to eliminate specific pathologic cells is creating more options for multiple myeloma patients. Several targeting approaches are in development.

Clinically relevant proteins can be difficult to distinguish against a background of more abundant molecules. The SomaScan® Assay offers a way to decipher proteomic health signatures.

To get the best out of big data you need plenty of power. Researchers in forecasting, engineering and life sciences are realizing the benefits of cloud-based computing.

Nearly 30 years ago, variations in the BRCA1/BRCA2 genes were found to significantly increase the risk of hereditary breast and ovarian cancers. As more gene variations are identified, what are the implications for patients and their families?

Leading surgical, bioprinting and imaging facilities at the Center for Biomedical Research in Vienna aim to bring new possibilities in cardiovascular medicine.

New technologies to overcome gene-therapy bottlenecks and use organoids clinically could result in fresh treatments for debilitating neurodegenerative and digestive diseases.

A conversation with Athanasios Typas, group leader in the Genome Biology Unit at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, and winner of the 2022 Liliane Bettencourt Prize for Life Sciences from Fondation Bettencourt Schueller

An enzyme that modifies tumour surface glycans so that cells can break free and travel to other parts of the body is identified as crucial for ovarian cancer metastasis.

Bioimaging insights are helping researchers at the Rudolf Virchow Center to improve the understanding and treatment of disease.

Dynamic single-molecule imaging is unravelling long-standing mysteries of DNA repair, including the untold activity of proteins involved.

Medicines Discovery Catapult is connecting drug discovery innovators to the technologies and expertise needed to drive their projects to success.

Neurologic and orthopaedic research at Atlantic Health System is raising standards in applications ranging from brain cancer to joint reconstruction.

Machine learning is now being used to assess injury risks of football athletes.

With soaring energy bills currently a global concern, researchers are looking for ways to keep buildings sustainably insulated.

An AI-enabled system that selects the best model for predicting infection patterns could improve the accuracy and efficiency of pandemic management.